# Edit Status: Recipe 13.7 - Disease-Gene-Drug Relationship Graph

**Editor:** TechEditor
**Date:** 2026-06-01
**Verdict:** Publication-ready (with deferred TODOs for TechWriter follow-up)

---

## Changes Applied

1. **V1 (MEDIUM) - Fixed directly.** Rewrote "Why These Services" Neptune paragraph to replace doc-voice with conversational tone matching the rest of the recipe. The original read like AWS documentation; the revision uses the same engineer-explaining-over-lunch voice found throughout.

2. **A5 (LOW) - Fixed directly.** Clarified performance benchmark: "200-500ms" now specifies this is Neptune traversal only, with end-to-end latency (500-800ms warm, 2-4s cold start) noted.

## Deferred Findings (TODO markers placed)

| Finding | Severity | Location | Marker Placed |
|---------|----------|----------|---------------|
| S1 | HIGH | Prerequisites, IAM row | Yes - split read-only vs read-write roles |
| S2 | HIGH | Prerequisites, BAA row | Yes - GINA compliance expansion |
| N1 | HIGH | Prerequisites, VPC row | Yes - complete VPC endpoint list |
| S3 | MEDIUM | Step 5 heading | Yes - input validation |
| S4 | MEDIUM | Prerequisites, CloudTrail row | Yes - audit log enablement |
| A1 | MEDIUM | Step 6 heading | Yes - zero-downtime update strategy |
| A2 | MEDIUM | After architecture diagram | Yes - query failure handling |
| A3 | MEDIUM | After Step 2 code block | Yes - ambiguity exclusion strategy |
| A4/N3 | MEDIUM | After Cost Estimate row | Yes - read replica and Multi-AZ |
| N2 | MEDIUM | After Cost Estimate row | Yes - security group guidance |
| S5 | LOW | After Encryption row | Yes - KMS CMK with rotation |

## Editorial Checklist Results

- ✅ **Grammar and mechanics** - Clean throughout. No issues found.
- ✅ **Code formatting** - All fenced blocks have language tags (or are generic pseudocode). Inline code used for service names and API calls. Consistent indentation.
- ✅ **Link verification** - All URLs are well-formed. One pre-existing TODO flags unverified AWS sample repo links (preserved).
- ✅ **Header hierarchy** - H1 title, H2 major sections, H3 subsections, H4 for code steps. No skipped levels.
- ✅ **Readability** - Short paragraphs, active voice, no run-on sentences.
- ✅ **Voice drift** - One instance fixed (V1). No em dashes. No doc-voice. No announcement statements. No LinkedIn tone.
- ✅ **RECIPE-GUIDE compliance** - All required sections present in correct order.
- ✅ **Vendor balance** - Excellent 70/30 split. Technology section entirely vendor-agnostic.

## Notes

The recipe is exceptionally well-written. The pharmacogenomics domain modeling is clinically accurate, the voice is strong and consistent, and the structure follows the cookbook pattern precisely. The deferred findings are all additive (expanding existing content with more detail) rather than corrective. No structural or factual issues found.

Code review passed with one WARNING (double-serialization comment in Python companion) that does not affect the main recipe file.
